🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
299,00 USD
Máx. histórico
322,75
6 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-7,36%
Rango 52 semanas
175,89 – 326,63
Variación hoy
-5,42%
Cierre anterior
316,13
Rango de hoy
297,63 – 318,98
Volumen hoy
247.610
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 120,08 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 350,92 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 10 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 27/05/2020 | 66,36 | 66,55 | 62,10 | 65,36 | -1,04% | 6,71% | 466.954 |
| 26/05/2020 | 69,35 | 69,51 | 65,68 | 66,04 | -2,55% | 5,53% | 465.030 |
| 22/05/2020 | 66,08 | 67,92 | 65,25 | 67,77 | +2,51% | 4,05% | 324.608 |
| 21/05/2020 | 63,99 | 66,64 | 63,37 | 66,11 | +2,63% | 5,10% | 321.241 |
| 20/05/2020 | 63,76 | 65,21 | 63,03 | 64,42 | +2,78% | 3,41% | 334.867 |
| 19/05/2020 | 64,25 | 65,12 | 62,66 | 62,68 | -3,26% | 3,82% | 322.524 |
| 18/05/2020 | 63,21 | 65,95 | 63,21 | 64,79 | +5,17% | 4,33% | 763.188 |
| 15/05/2020 | 58,35 | 62,59 | 57,42 | 61,60 | +4,94% | 8,86% | 643.765 |
| 14/05/2020 | 60,32 | 60,99 | 57,97 | 58,70 | -4,30% | 5,02% | 696.984 |
| 13/05/2020 | 63,57 | 64,73 | 61,10 | 61,34 | -4,31% | 5,70% | 849.269 |
| 12/05/2020 | 67,22 | 68,15 | 64,05 | 64,10 | -3,64% | 6,09% | 698.748 |
| 11/05/2020 | 63,20 | 66,77 | 62,80 | 66,53 | +3,49% | 6,29% | 766.555 |
| 08/05/2020 | 65,45 | 65,58 | 63,63 | 64,28 | -0,08% | 2,98% | 503.021 |
| 07/05/2020 | 62,68 | 67,64 | 61,82 | 64,33 | +1,61% | 9,29% | 762.066 |
| 06/05/2020 | 63,42 | 64,06 | 60,25 | 63,31 | +1,61% | 6,01% | 721.831 |
| 05/05/2020 | 60,80 | 62,35 | 59,89 | 62,31 | +4,28% | 4,04% | 575.156 |
| 04/05/2020 | 58,23 | 59,76 | 57,28 | 59,75 | +2,99% | 4,26% | 539.890 |
| 01/05/2020 | 60,27 | 60,42 | 56,87 | 58,02 | -5,65% | 5,88% | 583.332 |
| 30/04/2020 | 62,06 | 63,26 | 60,69 | 61,49 | -2,52% | 4,14% | 449.321 |
| 29/04/2020 | 65,22 | 69,99 | 61,19 | 63,08 | +8,52% | 13,50% | 1.157.366 |
| 28/04/2020 | 61,16 | 61,50 | 57,79 | 58,13 | -3,31% | 6,08% | 461.023 |
| 27/04/2020 | 61,75 | 62,30 | 59,89 | 60,12 | -1,29% | 3,90% | 352.500 |
| 24/04/2020 | 58,43 | 61,20 | 57,41 | 60,90 | +5,11% | 6,49% | 385.842 |
| 23/04/2020 | 60,99 | 63,55 | 55,96 | 57,94 | -4,15% | 12,44% | 919.962 |
| 22/04/2020 | 61,74 | 61,74 | 58,40 | 60,45 | +0,56% | 5,42% | 380.232 |
| 21/04/2020 | 59,43 | 61,63 | 58,63 | 60,11 | -1,00% | 5,05% | 681.275 |
| 20/04/2020 | 57,47 | 61,35 | 56,94 | 60,72 | +3,56% | 7,67% | 888.543 |
| 17/04/2020 | 58,08 | 62,68 | 56,78 | 58,63 | +6,07% | 10,15% | 1.037.782 |
| 16/04/2020 | 55,62 | 56,76 | 54,04 | 55,27 | +0,25% | 4,90% | 349.775 |
| 15/04/2020 | 54,63 | 55,43 | 52,81 | 55,13 | -3,01% | 4,80% | 658.352 |